Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Ampronix
Demo Company

Optical Coherence Tomography Shown to Predict Tumor Margins Effectively

By Medimaging International staff writers
Posted on 28 Jan 2013
Image: The VivoSight optical coherence tomography (OCT) scanner (Photo courtesy of Michelson Diagnostics).
Image: The VivoSight optical coherence tomography (OCT) scanner (Photo courtesy of Michelson Diagnostics).
A precise determination of tumor margins is vital for the effective treatment of skin cancer patients. This is particularly true for patients undergoing Mohs micrographic surgery, where complete tumor removal may require repeated invasive procedures.

Recent studies conducted in two US Healthcare facilities used the VivoSight optical coherence tomography (OCT) scanner, manufactured by Michelson Diagnostics, Ltd. (South London, UK), to prospectively improve clinically estimated tumor margins prior to Mohs micrographic surgery.

The first, a 52-patient study, conducted by Prof. Dan Seigel, from the department of dermatology, State University of New York Downstate Medical Center (Brooklyn, NY, USA), concluded that “OCT assessment has the potential to reduce the excised area without compromising the integrity of tumor-free borders.” The study’s findings were published January 2013 in the journal Dermatologic Surgery.

Another case study of a patient with very ill defined margins concluded that, “High-resolution imaging with a multibeam OCT device can accurately predict tumor margins of a BCC prior to Mohs micrographic surgery […] with any tumor, particularly ill-defined ones, the use of OCT could potentially reduce the number of stages required to clear the tumor leading to shorter operative times and reduction of cost.”

The findings were published December 2012 in the journal Case Reports in Dermatology by researchers from the Permanente Medical Group (Elk Grove, CA, USA) and SkinCare Physicians (Chestnut Hill, MA, USA).

Dr. Gertraud Kraehn-Senftleben, a dermatologists from Blaubeuren, Germany, and a member of the German Onkoderm Network, and one of the first clinicians to use the VivoSight OCT scanner in routine clinical practice, commented, “These studies reflect the day to day experience in our clinic. We routinely scan tumor margins prior to micrographic surgery and our experience of more than 150 patients is that it reduces the amount of repeat surgery required. This is a great benefit for both the patient and the dermatologist.”

Related Links:
Michelson Diagnostics
State University of New York Downstate Medical Center
SkinCare Physicians



Channels

MRI

view channel
Image: T1-weighted brain MR imaging showing significantly greater gray matter volume in female healthy control subjects than in women with substance dependence (photo courtesy of RSNA).

MRI Study Shows Evidence for Long-Term Effects on Brain Volume in Women Following Stimulant Drug Abuse

A study show excessive use of stimulant drugs has long-term effects on the volume of brain tissue in women. The researchers intended to determine how the brains of men and women, previously dependent... Read more

Ultrasound

view channel

New Guideline Released for the Diagnosis of Heart Detects Using Echocardiograms

New guidelines for the assessment of Atrial Septal Defects (ASD) and Patent Foramen Ovale (PFO) using echocardiography have been released by the American Society of Echocardiography (ASE) and the Society for Cardiac Angiography and Interventions (SCAI). The paper is being published in the August 2015, issue of the Journal... Read more

Nuclear medicine

view channel

Clinical Study Shows Added Value of Amyloid PET Imaging in the Diagnosis and Treatment of Dementia

Early-onset dementia patients could benefit from a new PET imaging agent developed by a major medical imaging vendor. The results of a clinical study showing the effectiveness of the amyloid PET imaging agent were presented at the Alzheimer’s Association International Conference (AAIC 2015) in Washington DC (USA).... Read more

Imaging IT

view channel
Image: Siemens Healthcare’s syngo.via MM Oncology facilitates compliance by clinicians to British Thoracic Society guidelines for the investigation and management of pulmonary nodules.(Photo courtesy of Siemens Healthcare).

Oncology Software Update Compliant with New BTS Guidelines

A key diagnostic imaging vendor has announced that it has modified its oncology software solution to ensure compliance with new British Thoracic Society (BTS) guidelines for lung nodule screening.... Read more

Industry News

view channel

International Healthcare Solutions Provider and US Healthcare Consultancy Agree Strategic Partnership

A leading US healthcare consultancy and an international Healthcare Information Technology (HIT) solutions provider have forged a partnership to find joint opportunities in the medical imaging market. HIT systems are intended to help clinicians make clinical decisions, and can be designed so that they can predict which... Read more
 

Events

11 Sep 2015 - 12 Sep 2015
19 Sep 2015 - 24 Sep 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.